Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015841
Chunk: 161

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 161
---
 |       134,673 |        36,114 |      10,213 |             9,471 |
| December 31, 2023(7) |       158,004 |        12,125 |       8,178 |                 - |

Notes:

(1)Audit Fees include fees for performance of the annual audit of the Company's financial statements, reviews of quarterly financial statements, reviews of periodic reports and reviews of other documents required by legislation or regulation.

(2)Audit-Related Fees include fees related to comfort letters, consents and reviews of securities filings.

(3)Tax Fees include fees billed for tax compliance, tax advice and tax planning professional services. These services included reviewing tax returns and assisting in responses to government tax authorities.

(4)All other fees include aggregate fees billed for professional services which included accounting advice.

(5)Aggregate fees for the financial year ending December 31, 2024 billed by EisnerAmper LLP.

(6)Aggregate fees for the financial year ending December 31, 2024 billed by MNP LLP.

(7)Aggregate fees for the financial year ending December 31, 2023 were billed by MNP LLP.

<div align='center'>117</div>

Compensation Committee

The purpose of the Compensation Committee is to assess and make recommendations to the Board regarding certain compensation matters, including, but not limited to, relating to the development of human resource strategy, policies and programs, the proper utilization of human resources within the Company, with special focus on senior management succession, development and compensation, the compensation of directors and senior executives and other employee benefits.

The Compensation Committee is required to review and assess the adequacy of its charter periodically as conditions dictate, but at least annually, to ensure compliance with any rules or regulations and recommend any modifications to its charter if and when appropriate to the Board for its approval.

Composition of the Compensation Committee

As of the date of this prospectus, the Compensation Committee is comprised of Dr. Larry Kaiser, Robert J. Ciaruffoli, William Ashton, and Dr. Sara R. May, all of whom are considered independent.

Compensation Committee Charter

The Board has adopted a written charter for the Compensation Committee, which sets out the Compensation Committee's responsibilities, including:

reviewing and recommending on an annual basis, the remuneration of our senior executives to the Board, including any incentive plans of directors and any remuneration policies;

reviewing the CEO's goals and objectives, including corporate goals